...
首页> 外文期刊>Manufacturing Chemist: Pharmaceutical Development, Formulation, Processing and Outsourcing >Ashland launches two excipients to aid formulation and solubility
【24h】

Ashland launches two excipients to aid formulation and solubility

机译:亚什兰推出两种赋形剂,以帮助配方和溶解性

获取原文
获取原文并翻译 | 示例
           

摘要

Ashland says its newly launched range of directly compressible Benecel DC hypromellose (HPMC) delivers innovation and efficiency in the tablet-making process without compromising the performance of the final product. Due to fierce competition and expansion into emerging markets, oral-dosage formulators are seeking tablet ingredients to deliver both the desired tablet functionalities and production efficiencies. Typically, to manufacture a controlled-release tablet, the ingredients powder must first be granulated to be compressed into the solid-dosage form. With Benecel DC HPMC controlled-release matrix former, the ingredients mix can be directly compressed into the tablet.
机译:亚什兰(Ashland)表示,其新推出的可直接压缩的Benecel DC羟丙甲纤维素(HPMC)系列可在制片过程中提供创新和效率,而不会影响最终产品的性能。由于激烈的竞争和向新兴市场的扩展,口服制剂设计师正在寻求片剂成分以提供所需的片剂功能和生产效率。通常,为了制造控释片剂,必须首先将成分粉末造粒以压制成固体剂型。使用Benecel DC HPMC控释基质形成剂,可以将成分混合物直接压制成片剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号